Overview
To investigate the role of histological and moleculr profile of endometrial cancer patietns in predicting the risk of nodal metastases in endometrila cancer patients.
Eligibility
Inclusion Criteria:
- Written informed consent
- Histologically confirmed endometrila cancer
- Data on molecular genomic profiling (POLE mutated, p53 abnormalities, MMRd/MSI-H, and NSMP)
- Data on histological characteristics of the ttumor
- Execution of sentinel node mapping
- Data on sentinel node status (negative vs. positive)
Exclusion Criteria:
- Stage IVB endoemtrial cancer
- consent withdraw